Page last updated: 2024-09-04

2,3-dinor-6,15-diketo-13,14-dihydroprostaglandin f1alpha and Thrombophilia

2,3-dinor-6,15-diketo-13,14-dihydroprostaglandin f1alpha has been researched along with Thrombophilia in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abramov, A; De Raucourt, E; Durst, R; Eldor, A; Gillis, S; Godefray, YC; Goldfarb, A; Guillin, MC; Hy-Am, E; MacLouf, J; Rachmilewitz, EA1

Other Studies

1 other study(ies) available for 2,3-dinor-6,15-diketo-13,14-dihydroprostaglandin f1alpha and Thrombophilia

ArticleYear
A chronic hypercoagulable state in patients with beta-thalassaemia major is already present in childhood.
    British journal of haematology, 1999, Volume: 107, Issue:4

    Topics: Adolescent; Adult; beta-Thalassemia; Blood Coagulation Factors; Child; Child, Preschool; Complement Inactivator Proteins; Glycoproteins; Humans; Mutation; Plasminogen; Prostaglandins F, Synthetic; Protein C; Protein S; Receptors, Complement; Thrombophilia; Thromboxane B2

1999